Neuren Pharmaceuticals Ltd. (NURPF)
12.88
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
Neuren Pharmaceuticals Market Cap: 1.627B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 60.72M |
| Kazia Therapeutics Ltd. | 21.38M |
| Immutep Ltd. | 363.90M |
| Propanc Biopharma, Inc. | 10.84M |
| Mesoblast Ltd. | 2.437B |
Market Cap Related Metrics
| PE Ratio | 17.15 |
| PS Ratio | 11.72 |
| PEG Ratio | 0.1059 |
| Price to Free Cash Flow | 19.14 |
| Price | 12.88 |
| Earnings Yield | 5.83% |
| PEGY Ratio | 0.1059 |
| Operating PE Ratio | 13.91 |
| Normalized PE Ratio | 17.08 |